Depomed, Inc. (DEPO: Quote) Thursday said it acquired all rights to Zipsor liquid filled capsules from Xanodyne Pharmaceuticals, Inc., in return for $25.9 million of cash and potential milestone payments based on sales of Zipsor and assumption of certain liabilities.
Zipsor is a non-steroidal anti-inflammatory drug, known to relieve mild to moderate acute pain in adults.
Click here to receive FREE breaking news email alerts for DEPOMED INC and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com